Company news

Oxurion NV news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Interim Financial Report — Half-year results as of 30 June 2026 (EN)

September 30, 2026

Oxurion: Oxurion Publishes First Half 2026 Results

September 30, 2026

Oxurion: Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO

September 30, 2026

Oxurion: Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV

July 21, 2026

Oxurion: Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module

July 6, 2026

Oxurion: Oxurion launches a software-driven growth strategy with Exagis

June 8, 2026

Oxurion: Oxurion Announces Results on the Annual Shareholders’ Meeting of 1 June 2026

June 3, 2026

Oxurion: Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services

June 2, 2026

Oxurion - Termination of discussions for the French CRO project (LOI dated 13/10/25) and prioritization of the international target (LOI dated 19/03/26)

June 2, 2026

Publication Annual Report - Annual Shareholders Meeting

April 30, 2026

Postponement Annual Shareholders Meeting

April 7, 2026

Oxurion: Oxurion signs a letter of intent for the acquisition of an international CRO

March 19, 2026

Oxurion Extends Its Financing Program

March 10, 2026

Oxurion confirms continuation of discussions regarding its proposed acquisition of a French CRO

February 27, 2026

Oxurion: Oxurion secures a binding EUR 30 million financing facility dedicated to investments in digital and crypto assets

December 1, 2025

Decks

The 5 newest of 9 decks. Every deck is listed under its year.